Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
25 mg | Warenkorb auf Verfügbarkeit prüfen | € 1.400,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
antipyrine
manufacturer/tradename
USP
bp
287 °C/265 mmHg (lit.)
mp
126-128 °C (lit.)
application(s)
pharmaceutical (small molecule)
pharmaceutical
pharmaceutical
format
neat
storage temp.
2-8°C
SMILES string
CC1=NN(C(=O)C1)c2ccccc2
InChI
1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3
InChI key
QELUYTUMUWHWMC-UHFFFAOYSA-N
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
- Antipyrine
- Antipyrine and Benzocaine Otic Solution
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description A free radical scavenger and antioxidant that reduces post-ischemic brain injury. | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard |
| manufacturer/tradename USP | manufacturer/tradename Calbiochem® | manufacturer/tradename USP | manufacturer/tradename USP |
| grade pharmaceutical primary standard | grade - | grade pharmaceutical primary standard | grade pharmaceutical primary standard |
| format neat | format - | format neat | format neat |
| application(s) pharmaceutical (small molecule) | application(s) - | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) |
| agency USP | agency - | agency USP | agency USP |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. - | storage temp. 15-25°C |
Signalwort
Warning
Gefahrencodes
Sicherheitshinweise
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2
Lagerklasse
11 - Combustible Solids
Was ist los?
WGK 1
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.




